한국인 루푸스 임상연구의 현재와 미래 = The Present and Future of Clinical Research for Korean Lupus Patients

다국어 초록 (Multilingual Abstract)

Systemic lupus erythematosus (SLE) is considered to be the prototype of systemic autoimmune disease because it involves the most immune cells and it can affect all organs of the human body. Despite the advances in understanding the etiology and pathogenesis of SLE, a sobering fact is that only a few drugs have been licensed for its treatment. This may be associated with the difficulties in performing clinical trials due to its diverse clinical manifestations and comorbidities of SLE, as well as difficulties in determining the disease outcome. To determine the natural course and drug response of SLE patients, various observational studies have been conducted in Western countries. However, in Korea, sufficiently powered prospective clinical studies are scarce. In this review, we conducted a systematic review to be aware of the current status of clinical studies in Korean SLE patients. Identifying the topics for clinical studies that have been performed helps determine how the clinical research should be conducted for Korean SLE patients.

참고문헌 (Reference)

1 박윤정, "한국인 전신홍반루푸스 환자에서 골밀도 감소의 위험인자" 대한류마티스학회 18 (18): 19-25, 2011

2 염지연, "치료 불응성 루푸스 신염 환자에 대한 Rituximab 치료" 대한류마티스학회 12 (12): 251-262, 2005

3 윤창기, "전신홍반루프스 환자에서 발생한 망막병증" 대한안과학회 50 (50): 1215-1220, 2009

4 김보영, "전신성 홍반성 루프스 환자에서 발생하는 이과적 증상" 대한이비인후과학회 51 (51): 416-421, 2008

5 신정현, "전신성 홍반성 루푸스와 임신의 상호 영향에 대한 연구" 대한내과학회 65 (65): 511-519, 2003

6 백혜성, "전신성 홍반성 루푸스 산모의 출산아의 임상적 고찰" 대한소아과학회 49 (49): 381-387, 2006

7 유선진, "루푸스 신염의 임상지표와 조직학적 분류의 연관성" 대한신장학회 28 (28): 410-417, 2009

8 Pons-Estel GJ, "Understanding the epidemiology and progression of systemic lupus erythematosus" 39 : 257-268, 2010

9 Kwok SK, "Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study" 18 : 16-21, 2009

10 Lau CS, "The socioeconomic burden of SLE" 5 : 400-404, 2009

11 Yun JE, "The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea" 20 : 127-132, 2002

12 Koo HS, "The effects of cyclophosphamide and mycophenolate on end-stage renal disease and death of lupus nephritis" 20 : 1442-1449, 2011

13 Kim YG, "The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment" 47 : 311-314, 2008

14 Kang KY, "The causes of death in Korean patients with systemic lupus erythematosus over 11 years" 20 : 989-997, 2011

15 구영석, "The Evolution of Lupus Activity among Patients with End-Stage Renal Disease Secondary to Lupus Nephritis" 연세대학교의과대학 45 (45): 199-206, 2004

16 Chin HJ, "The Clinicopathologic Findings and Prognostic Factors Related to Death of Patients with Lupus Nephritis" 19 : 1129-1142, 2000

17 Kang HS, "The Clinical Characteristics and Outcome of Neonates born to Systemic Lupus Erythematosus Mothers" 13 : 139-148, 2006

18 Yang HI, "The Avascular Necrosis of Bone in Sle" 3 : 118-125, 1996

19 Lee T, "Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis" 19 : 974-980, 2010

20 Gladman D, "Systemic lupus international collaborative clinics: development of a damage index in systemic lupus erythematosus" 19 : 1820-1821, 1992

21 Lim MK, "Systemic lupus erythematosus: brain MR imaging and single-voxel hydrogen 1 MR spectroscopy" 217 : 43-49, 2000

22 D'Cruz DP, "Systemic lupus erythematosus" 369 : 587-596, 2007

23 Lim MK, "Serum ferritin as a serologic marker of activity in systemic lupus erythematosus" 20 : 89-93, 2001

24 Kim YG, "Serum cholesterol in idiopathic and lupus-related protein-losing enteropathy" 17 : 575-579, 2008

25 Park MC, "Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy" 13 : 569-574, 2004

26 Suh CH, "Risk factors for infection and role of C-reactive protein in Korean patients with systemic lupus erythematosus" 19 : 191-194, 2001

27 Kim JM, "Reactive hemophagocytic syndrome in adult Korean patients with systemic lupus erythematosus: a case-control study and literature review" 39 : 86-93, 2012

28 Kim HY, "Pulmonary tuberculosis in patients with systematic lupus erythematosus" 173 : 1639-1642, 1999

29 김소영, "Prognosis of Neonates in Pregnant Women with Systemic Lupus Erythematosus" 연세대학교의과대학 49 (49): 515-520, 2008

30 이유현, "Prevalence of Human Papilloma Virus Infections and Cervical Cytological Abnormalities among Korean Women with Systemic Lupus Erythematosus" 대한의학회 25 (25): 1431-1437, 2010

31 Shim JS, "Prevalence and incidence of systemic lupus erythematosus in South Korea" 2013

32 우광숙, "Prevalence and Clinical Associations of Lupus Anticoagulant, Anticardiolipin Antibodies, and Anti-beta2-glycoprotein I Antibodies in Patients with Systemic Lupus Erythematosus" 대한진단검사의학회 30 (30): 38-44, 2010

33 Ko HS, "Pregnancy outcomes and appropriate timing of pregnancy in 183 pregnancies in Korean patients with SLE" 8 : 577-583, 2011

34 Moon SJ, "Predictors of renal relapse in Korean patients with lupus nephritis who achieved remission six months following induction therapy" 22 : 527-537, 2013

35 Yoo CW, "Predictors of renal outcome in diffuse proliferative lupus nephropathy: data from repeat renal biopsy" 15 : 1604-1608, 2000

36 So MW, "Predictive value of remission status after 6 months induction therapy in patients with proliferative lupus nephritis: a retrospective analysis" 30 : 1399-1405, 2011

37 Oh DH, "Precuneus hypoperfusion plays an important role in memory impairment of patients with systemic lupus erythematosus" 20 : 855-860, 2011

38 Jung SM, "Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome" 22 : 885-891, 2013

39 Su D, "Possible novel biomarkers of organ involvement in systemic lupus erythematosus" 2014

40 Yurkovich M, "Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies" 66 : 608-616, 2014

41 Oh SN, "Osteonecrosis in patients with systemic lupus erythematosus:MR imaging and scintigraphic evaluation" 28 : 305-309, 2004

42 Kim WU, "Obstetric Outcomes in Patients with Systemic Lupus Erythematosus" 4 : 131-138, 1997

43 Appel GB, "Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis" 20 : 1103-1112, 2009

44 문성진, "Mycophenolate Mofetil과 Cyclophosphamide의 증식성 루푸스 신염 치료 효과 비교" 대한내과학회 74 (74): 640-647, 2008

45 Bang SY, "Multicenter retrospective analysis of the effectiveness and safety of rituximab in korean patients with refractory systemic lupus erythematosus" 2012 : 565039-, 2012

46 Chun BC, "Mortality and cancer incidence in Korean patients with systemic lupus erythematosus: results from the Hanyang lupus cohort in Seoul, Korea" 14 : 635-638, 2005

47 Kim JM, "Meningitis in Korean patients with systemic lupus erythematosus: analysis of demographics, clinical features and outcomes; experience from affiliated hospitals of the Catholic University of Korea" 20 : 531-536, 2011

48 ter Borg EJ, "Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study" 33 : 634-643, 1990

49 오규찬, "MR Manifestations of the Brain in Neuropsychiatric Systemic Lupus Erythematosus Patients" 대한영상의학회 58 (58): 1-7, 2008

50 Saxena R, "Lupus nephritis: current update" 13 : 240-, 2011

51 Kwok SK, "Lupus enteritis: clinical characteristics, risk factor for relapse and association with anti-endothelial cell antibody" 16 : 803-809, 2007

52 Ni J, "Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis" 23 : 284-292, 2014

53 Chan TM, "Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis" 16 : 1076-1084, 2005

54 Her M, "Liver enzyme abnormalities in systemic lupus erythematosus: a focus on toxic hepatitis" 31 : 79-84, 2011

55 Kim HJ, "Invasive fungal infections in patients with systemic lupus erythematosus:experience from affiliated hospitals of Catholic University of Korea" 18 : 661-666, 2009

56 Kang KY, "Incidence of cancer among female patients with systemic lupus erythematosus in Korea" 29 : 381-388, 2010

57 Jeong SJ, "Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus" 41 : 268-274, 2009

58 Gatto M, "In-/off-label use of biologic therapy in systemic lupus erythematosus" 12 : 30-, 2014

59 Houssiau FA, "Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide" 46 : 2121-2131, 2002

60 Kim JM, "Idiopathic intracranial hypertension as a significant cause of intractable headache in patients with systemic lupus erythematosus:a 15-year experience" 21 : 542-547, 2012

61 Lee SG, "ISN/RPS 2003 class II mesangial proliferative lupus nephritis: a comparison between cases that progressed to class III or IV and cases that did not" 32 : 2459-2464, 2012

62 Sung YK, "Health-Related Quality of Life in Korean Patients with Systemic Lupus Erythematosus" 9 (9): S84-S95, 2002

63 Ha Y, "Glucocorticoid-induced diabetes mellitus in patients with systemic lupus erythematosus treated with high-dose glucocorticoid therapy" 20 : 1027-1034, 2011

64 González LA, "Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes" 22 : 1214-1224, 2013

65 Seong SS, "Effect of lower dose intravenous cyclophosphamide on remission induction in Korean patients with lupus nephritis" 28 : 453-458, 2008

66 Kwok SK, "Diffuse alveolar hemorrhage in systemic lupus erythematosus:risk factors and clinical outcome: results from affiliated hospitals of Catholic University of Korea" 20 : 102-107, 2011

67 Merrell M, "Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus" 1 : 12-32, 1955

68 Yun SJ, "Cross-sectional study of hair loss patterns in 122Korean systemic lupus erythematosus patients: a frequent finding of non-scarring patch alopecia" 34 : 451-455, 2007

69 Boumpas DT, "Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis" 340 : 741-745, 1992

70 조병식, "Comparison of the Clinical Manifestations, Brain MRI and Prognosis between Neurobe？et'S Disease and Neuropsychiatric Lupus" 대한내과학회 22 (22): 77-86, 2007

71 강석휘, "Comparison of Clinical Outcomes by Different Renal Replacement Therapy in Patients with End-Stage Renal Disease Secondary to Lupus Nephritis" 대한내과학회 26 (26): 60-67, 2011

72 Chun JH, "Clinical Manifestations On Systemic Lupus Erythematosus" 1 : 159-168, 1994

73 Lee CH, "Clinical Evaluation of Neuropsychiatric Lupus Erythematosus" 3 : 126-133, 1996

74 Bongu A, "Can morbidity and mortality of SLE be improved?" 16 : 313-332, 2002

75 Byun JY, "CT features of systemic lupus erythematosus in patients with acute abdominal pain: emphasis on ischemic bowel disease" 211 : 203-209, 1999

76 Sung YK, "Assessment of damage in Korean patients with systemic lupus erythematosus" 34 : 987-991, 2007

77 Mok CC, "Asian Lupus Nephritis Network (ALNN). Overview of lupus nephritis management guidelines and perspective from Asia" 16 : 625-636, 2013

78 Akhter E, "Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers" 20 : 1267-1274, 2011

79 Kim WU, "Adult respiratory distress syndrome in systemic lupus erythematosus: causes and prognostic factors: a single center, retrospective study" 8 : 552-557, 1999

80 Lee SW, "Adjusted neutropenia is associated with early serious infection in systemic lupus erythematosus" 23 : 509-515, 2013

81 Lee CK, "Acute abdominal pain in systemic lupus erythematosus:focus on lupus enteritis (gastrointestinal vasculitis)" 61 : 547-550, 2002

82 Slawsky KA, "A structured literature review of the direct costs of adult systemic lupus erythematosus in the US" 63 : 1224-1232, 2011

83 Bae YI, "A clinical and epidemiological study of lupus erythematosus at a tertiary referral dermatology clinic in Korea" 18 : 1320-1326, 2009

84 김정은, "21년간의 루푸스 신염 치료 경험 단일 기관 성적" 대한신장학회 28 (28): 113-121, 2009